SCHEMBL24927340

SCHEMBL24927340

N#Cc1cc(-c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)cc2)cc(-c2ccc(-n3c4ccccc4c4cc(C#N)ccc43)c(C#N)c2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
FASN P49327 1/20 0.34
PTGER4 P35408 1/20 0.32
PGR P06401 1/20 0.32
ENPP3 O14638 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GRIA2 P42262 1/20 0.32
GRIA4 P48058 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
ALDH1A3 P47895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24927230 0.98 MEN1 (0.34) MEN1KMT2AFASNPTGER4PGR
SCHEMBL24927506 0.96 MEN1 (0.36) MEN1KMT2AFASNPTGER4ENPP3
SCHEMBL24926868 0.96 MEN1 (0.36) MEN1KMT2AFASNPTGER4ENPP3
SCHEMBL24927248 0.96 MEN1 (0.37) MEN1KMT2AFASNPTGER4ENPP3
SCHEMBL24927193 0.96 MEN1 (0.37) MEN1KMT2AFASNPTGER4ENPP3
SCHEMBL24927147 0.94 MEN1 (0.36) MEN1KMT2AFASNPTGER4ENPP3
SCHEMBL24927504 0.93 MEN1 (0.37) MEN1KMT2AFASNCYP11B1CYP11B2
SCHEMBL24926873 0.93 MEN1 (0.37) MEN1KMT2AFASNCYP11B1CYP11B2
SCHEMBL24927495 0.93 MEN1 (0.38) MEN1KMT2AFASNALDH1A1GABRA1
SCHEMBL24926828 0.93 MEN1 (0.38) MEN1KMT2AFASNALDH1A1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME NR0B1, CRY1, CCNT1 MEN1 404/4885KMT2A 3254/4885FASN 4199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.